FdaApplication
ANDA 216885
Identifiers
- fda_app_no: ANDA216885
Properties
| Property | Value |
|---|---|
| applicant_name | PRINSTON PHARMACEUTICAL INC |
| application_type | ANDA |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| SITAGLIPTIN PHOSPHATE AND METFORMIN HYDROCHLORIDE | METFORMIN HYDROCHLORIDE, SITAGLIPTIN PHOSPHATE | 50MG | TABLET;FILM COATED |
| SITAGLIPTIN PHOSPHATE AND METFORMIN HYDROCHLORIDE | METFORMIN HYDROCHLORIDE, SITAGLIPTIN PHOSPHATE | 500MG | TABLET;FILM COATED |
| SITAGLIPTIN PHOSPHATE AND METFORMIN HYDROCHLORIDE | METFORMIN HYDROCHLORIDE, SITAGLIPTIN PHOSPHATE | 1000MG | TABLET;FILM COATED |
3 products